User profiles for James P. Cooney
 | James Patrick CooneyThe Walter and Eliza hall institute Verified email at wehi.edu.au Cited by 1039 |
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
…, C Grohmann, Y Shibata, ZY Gan, JP Cooney… - The EMBO …, 2020 - embopress.org
The SARS‐CoV‐2 coronavirus encodes an essential papain‐like protease domain as part
of its non‐structural protein (nsp)‐3, namely SARS2 PLpro, that cleaves the viral polyprotein, …
of its non‐structural protein (nsp)‐3, namely SARS2 PLpro, that cleaves the viral polyprotein, …
[PDF][PDF] Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway
Cell death plays an important role during pathogen infections. Here, we report that interferon-γ
(IFNγ) sensitizes macrophages to Toll-like receptor (TLR)-induced death that requires …
(IFNγ) sensitizes macrophages to Toll-like receptor (TLR)-induced death that requires …
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
…, A Adair, LJ Chan, JP Cooney… - Proceedings of the …, 2021 - National Acad Sciences
Neutralizing antibodies are important for immunity against SARS-CoV-2 and as therapeutics
for the prevention and treatment of COVID-19. Here, we identified high-affinity nanobodies …
for the prevention and treatment of COVID-19. Here, we identified high-affinity nanobodies …
Programmed cell death: the pathways to severe COVID-19?
Two years after the emergence of SARS-CoV-2, our understanding of COVID-19 disease
pathogenesis is still incomplete. Despite unprecedented global collaborative scientific efforts …
pathogenesis is still incomplete. Despite unprecedented global collaborative scientific efforts …
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates
The diversity of COVID-19 disease in otherwise healthy people, from seemingly asymptomatic
infection to severe life-threatening disease, is not clearly understood. We passaged a …
infection to severe life-threatening disease, is not clearly understood. We passaged a …
[HTML][HTML] Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies
…, BM Tran, V Duvivier, P Arandjelovic, JP Cooney… - Gastroenterology, 2022 - Elsevier
Background & Aims Necroptosis is a highly inflammatory mode of cell death that has been
implicated in causing hepatic injury including steatohepatitis/ nonalcoholic steatohepatitis (…
implicated in causing hepatic injury including steatohepatitis/ nonalcoholic steatohepatitis (…
[PDF][PDF] Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
Potent neutralizing monoclonal antibodies are one of the few agents currently available to
treat COVID-19. SARS-CoV-2 variants of concern (VOCs) that carry multiple mutations in the …
treat COVID-19. SARS-CoV-2 variants of concern (VOCs) that carry multiple mutations in the …
[PDF][PDF] Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
P Arandjelovic, Y Kim, JP Cooney, SP Preston… - Cell Reports …, 2023 - cell.com
HIV-1 persists indefinitely in people living with HIV (PLWH) on antiretroviral therapy (ART). If
ART is stopped, the virus rapidly rebounds from long-lived latently infected cells. Using a …
ART is stopped, the virus rapidly rebounds from long-lived latently infected cells. Using a …
[HTML][HTML] insights into drug repurposing, as well as specificity and compound properties of piperidine-based SARS-CoV-2 PLpro inhibitors
…, T Klemm, M Doerflinger, JP Cooney… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 pandemic continues unabated, emphasizing the need for additional antiviral
treatment options to prevent hospitalization and death of patients infected with SARS-CoV-2. …
treatment options to prevent hospitalization and death of patients infected with SARS-CoV-2. …
[HTML][HTML] Rapid detection of monkeypox virus using a CRISPR-Cas12a mediated assay: a laboratory validation and evaluation study
…, I Savic, J Prestedge, L Williams, JP Cooney… - The Lancet …, 2023 - thelancet.com
Background The 2022 outbreak of mpox (formerly known as monkeypox) led to the spread of
monkeypox virus (MPXV) in over 110 countries, demanding effective disease management …
monkeypox virus (MPXV) in over 110 countries, demanding effective disease management …